Hinge Health jumps in market debut, ending IPO dry spell
Shares of Hinge Health jumped 22% above the initial public offering price in the company’s New York Stock Exchange debut Thursday, bringing its market capitalization to more than $3 billion.…
Innovative blood testing tech could spell the end of needle phobia
UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle needle phobia, a condition that affects at least…